PYMNTS.com February 12, 2025

Walgreens Boots Alliance-backed healthcare clinic chain VillageMD is reportedly working with advisers to explore a sale, restructuring or other options.

This move comes after Walgreens CEO Tim Wentworth said during a January earnings call that the company plans to divest VillageMD, Bloomberg reported Wednesday (Feb. 12).

A Walgreens spokesperson told Bloomberg that Walgreens “is continuing to work toward executing its stated goal of securing an endpoint for its investment in VillageMD, consistent with Walgreens’ turnaround strategy.”

The company bought a controlling stake in VillageMD for $5.2 billion in 2021 as it sought new sources of revenue beyond its pharmacy and front-of-store offerings, according to the report.

The Walgreens unit that includes the stake in the healthcare clinic chain booked an...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Primary care, Provider
CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
Slideshow: PwC Report Identifies Top Trends in Pharma
Four AI Disruptions in 2025 That Will Reshape Pharma and Healthcare
Amazon's RxPass Shown to Improve Days' Supply, Refills, and Out-of-Pocket Costs for Common Medications
LinkedIn Founder Reid Hoffman’s New AI Startup May Revolutionize Cancer Care

Share This Article